QLGN icon

Qualigen Therapeutics

14 hedge funds and large institutions have $1.82M invested in Qualigen Therapeutics in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 0 closing their positions.

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
3
Closed
Calls
$10.9M
Puts
Net Calls
+$10.9M
Net Calls Change
-$637K
Name Market Value Shares Shares
Change
Shares
Change %
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$753K 293,059 -149,170 -34%
BBA
2
Baker Bros. Advisors
New York
$720K 279,999
DS
3
DRW Securities
Illinois
$111K 43,310 +14,000 +48%
Renaissance Technologies
4
Renaissance Technologies
New York
$89K 34,819 +24,769 +246%
AC
5
Armistice Capital
New York
$36K 14,000 -176,000 -93%
Vanguard Group
6
Vanguard Group
Pennsylvania
$36K 14,030 +14,030 New
S
7
SignatureFD
Georgia
$33K 13,000 +13,000 New
BlackRock
8
BlackRock
New York
$24K 9,333 +712 +8%
Wells Fargo
9
Wells Fargo
California
$3K 1,100
CIBC Private Wealth Group
10
CIBC Private Wealth Group
Georgia
$3K 1,000
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$3K 1,200
TDC
12
Thompson Davis & Co
Virginia
$2K 700 +700 New
UBS Group
13
UBS Group
Switzerland
$1K 200 -5,145 -96%
LTFS
14
Ladenburg Thalmann Financial Services
Florida
$1K 500